Patócs A - Search Results

1

Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background.

Nagy P, Papp J, Grolmusz VK, Bozsik A, Pócza T, Oláh E, Patócs A, Butz H. Nagy P, et al. Among authors: patocs a. Int J Mol Sci. 2024 Nov 22;25(23):12546. doi: 10.3390/ijms252312546. Int J Mol Sci. 2024. PMID: 39684258 Free PMC article.

2

Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients-Novel Variants from a Large National Center.

Bozsik A, Pócza T, Papp J, Vaszkó T, Butz H, Patócs A, Oláh E. Bozsik A, et al. Among authors: patocs a. Int J Mol Sci. 2020 Jun 30;21(13):4650. doi: 10.3390/ijms21134650. Int J Mol Sci. 2020. PMID: 32629901 Free PMC article.

3

Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes.

Butz H, Blair J, Patócs A. Butz H, et al. Among authors: patocs a. Endocrine. 2021 Mar;71(3):641-652. doi: 10.1007/s12020-021-02636-x. Epub 2021 Feb 11. Endocrine. 2021. PMID: 33570725 Free PMC article. Review.

4

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach.

Sarkadi B, Saskoi E, Butz H, Patocs A. Sarkadi B, et al. Among authors: patocs a. Int J Mol Sci. 2022 Jan 27;23(3):1450. doi: 10.3390/ijms23031450. Int J Mol Sci. 2022. PMID: 35163370 Free PMC article. Review.

5

Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study.

Bozsik A, Papp J, Grolmusz VK, Patócs A, Oláh E, Butz H. Bozsik A, et al. Among authors: patocs a. Cancer Res Treat. 2022 Oct;54(4):970-984. doi: 10.4143/crt.2021.1078. Epub 2022 Feb 8. Cancer Res Treat. 2022. PMID: 35167739 Free PMC article.

6

Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre.

Butz H, Bozsik A, Grolmusz V, Szőcs E, Papp J, Patócs A. Butz H, et al. Among authors: patocs a. Sci Rep. 2023 Aug 31;13(1):14259. doi: 10.1038/s41598-023-41481-y. Sci Rep. 2023. PMID: 37653074 Free PMC article.

7

Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer.

Madar L, Majoros V, Szűcs Z, Nagy O, Babicz T, Butz H, Patócs A, Balogh I, Koczok K. Madar L, et al. Among authors: patocs a. Int J Mol Sci. 2023 Oct 18;24(20):15334. doi: 10.3390/ijms242015334. Int J Mol Sci. 2023. PMID: 37895014 Free PMC article.

8

Cost-effectiveness of Genetic Testing of Endocrine Tumor Patients Using a Comprehensive Hereditary Cancer Gene Panel.

Patócs A, Nagy P, Papp J, Bozsik A, Antal B, Grolmusz VK, Pócza T, Butz H. Patócs A, et al. J Clin Endocrinol Metab. 2024 Nov 18;109(12):3220-3233. doi: 10.1210/clinem/dgae300. J Clin Endocrinol Metab. 2024. PMID: 38701358 Free PMC article.

9

[Evolution of molecular genetic methods in the clinical diagnosis of hereditary endocrine tumour syndromes].

Sarkadi B, Grolmusz VK, Butz H, Kövesdi A, Likó I, Nyirő G, Igaz P, Patócs A. Sarkadi B, et al. Among authors: patocs a. Orv Hetil. 2018 Feb;159(7):285-292. doi: 10.1556/650.2018.31036. Orv Hetil. 2018. PMID: 29429353 Review. Hungarian.

10

Brief Summary of the Most Important Molecular Genetic Methods (PCR, qPCR, Microarray, Next-Generation Sequencing, etc.).

Butz H, Patócs A. Butz H, et al. Among authors: patocs a. Exp Suppl. 2019;111:33-52. doi: 10.1007/978-3-030-25905-1_4. Exp Suppl. 2019. PMID: 31588527 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters